Results: Psoriasis

Results from Abstracts

Pick one of the followings

*Some genes may be words of complete meaning. In any case, if present, they are relevant key words.

Legend:

***	p-value <= 0.001
**	p-value <= 0.01
*	p-value <= 0.05
n.s.	not significant

Top Ranked Genes, Molecules or Short Names*

Tnf ***
Itch *
Impact *
Card11 *
Slurp1 *
Ada *
Ccl22 *
Aes *
Ifih1 *
Gabrg1 *
S100a8 *
Nnt *
Cxcl9 *
Flg *
Tlr8 *
Ccl3 n.s.
Il36g n.s.
Ccr6 n.s.
Nfe2l2 n.s.
Il23r n.s.
Il17c n.s.
Palm n.s.
Cd1a n.s.
Ust n.s.
Jak1 n.s.
Pi3 n.s.
Taz n.s.
Cyp1a2 n.s.
Cxcl1 n.s.
Ace n.s.
Acr n.s.
Bid n.s.
Tgfb1 n.s.
S100a7 n.s.
Il36rn n.s.
Card14 n.s.
Psd n.s.
Crp n.s.
Erap1 n.s.
Tlr9 n.s.
Tlr2 n.s.
Ahr n.s.
Cxcl8 n.s.
Cd14 n.s.
Hp n.s.
Pdc n.s.
Cd4 n.s.
Cers3 n.s.
Elovl4 n.s.
Elovl1 n.s.
Stat3 n.s.
Itgam n.s.
Il17ra n.s.
Bcl10 n.s.
Tbca n.s.
Pld6 n.s.
Ccdc66 n.s.
Aff3 n.s.
Mettl1 n.s.
Fyco1 n.s.
Lman1 n.s.
Lekr1 n.s.
Gipr n.s.
Anxa7 n.s.
Lnpep n.s.
Sytl2 n.s.
Aadacl2 n.s.
Il1b n.s.
Fut2 n.s.
Ctla4 n.s.
Adamtsl5 n.s.
Tlr7 n.s.
Fabp3 n.s.
Gnaq n.s.
S1pr2 n.s.
Saa1 n.s.
Il26 n.s.
Il17f n.s.
Tpo n.s.
Cxcl16 n.s.
Tnip1 n.s.
Lce3d n.s.
Ctnnal1 n.s.
Adamtsl3 n.s.
Dlx2 n.s.
Mxra8 n.s.
Dip2c n.s.
Plekhg6 n.s.
Fam172a n.s.
Tapbp n.s.
Drosha n.s.
Fpr2 n.s.
Casp3 n.s.
Malt1 n.s.
Il2 n.s.
Pcsk9 n.s.
Trex2 n.s.
B3gnt2 n.s.
Polh n.s.
Fosl1 n.s.

Top Ranked Key Phrases

Immune mediated inflammatory skin disease ***
Cal bd aerosol foam ***
Dermatology life quality index dlqi ***
Psoriasis area severity index pasi ***
Chronic inflammatory skin disorder ***
Phase iii clinical trials ***
Chronic inflammatory skin disease ***
Inflammatory bowel disease ibd ***
Severity index pasi score ***
Body surface area bsa ***
Chronic inflammatory skin diseases ***
Dermatology life quality index ***
Severe chronic plaque psoriasis ***
Body mass index ***
Inflammatory bowel disease ***
Systemic lupus erythematosus ***
Chronic inflammatory disease ***
Cross sectional study ***
Chronic inflammatory diseases ***
Severity index pasi ***
Inflammatory skin diseases ***
Real world setting ***
Nj drugs dermatol ***
Health related quality **
Generalized pustular psoriasis **
Hidradenitis suppurativa hs **
S disease cd **
Statistically significant difference **
Rheumatoid arthritis ra **
Psoriatic skin lesions **
Chronic plaque psoriasis **
Atopic dermatitis ad **
New safety signals **
Il 23 il 17 axis **
Increased cardiovascular risk **
Plaque type psoriasis **
Psoriatic arthritis psa **
Severe plaque psoriasis **
Patient reported outcomes **
Cross sectional *
Anti inflammatory *
Nf Κb *
Vitamin d *
RorΓt *
ΓΔ t cells *
T cells *
Severity index *
Mast cells *
Mouse model *
Cell cycle *
Inflammatory response *
Adverse events *
Mouse models *
Peripheral blood *
Odds ratio *
Flow cytometry n.s.
Inflammatory arthritis n.s.
Inflammatory diseases n.s.
Inflammatory disorders n.s.
Cell proliferation n.s.
Pasi score n.s.
Jak inhibitors n.s.
Significantly different n.s.
Immune cells n.s.
Inflammatory cytokines n.s.
Drug survival n.s.
Immune responses n.s.
Hla c*06 n.s.
Risk factor n.s.
Significantly higher n.s.
Statistically significant n.s.
Hacat cells n.s.
Disease activity n.s.
Clinical trials n.s.
Meta analysis n.s.
Blood samples n.s.
Skin disease n.s.
Cardiovascular disease n.s.
Chronic inflammation n.s.
Immune response n.s.
Normal skin n.s.
Significantly increased n.s.
Was associated n.s.
Multiple sclerosis n.s.
Psoriatic disease n.s.
Peripheral arthritis n.s.
Skin lesion n.s.
Autoimmune disease n.s.
Epidermal thickness n.s.
Study was n.s.
Open label n.s.
Psoriatic skin n.s.
S disease n.s.
Hla b27 n.s.
Th17 cells n.s.
Keratinocyte proliferation n.s.
Il 17a n.s.
Psoriasiform dermatitis n.s.
Significantly lower n.s.
Disease severity n.s.

Top Ranked Mesh Terms

Arthritis psoriatic ***
Skin ***
Middle aged ***
Young adult ***
Treatment outcome ***
Severity of illness index ***
Drug therapy ***
Adult ***
Dermatologic agents ***
Male ***
Pathology ***
Female ***
Psoriasis ***
Humans ***
Aged ***
Antibodies monoclonal ***
Case-control studies **
Inflammation **
Keratinocytes **
Tumor necrosis factor-alpha **
Cytokines **
Skin diseases **
Biological products **
Diagnosis **
Quality of life **
Epidemiology **
Adolescent **
Comorbidity **
Interleukin-17 **
Administration cutaneous **
Dermatitis atopic **
Mice **
Adalimumab **
Risk factors **
Surveys and questionnaires **
Signal transduction **
Th17 cells **
Disease models animal **
Anti-inflammatory agents **
Cross-sectional studies **
Cell proliferation **
Methotrexate *
Mice inbred balb c *
Pruritus *
Risk assessment *
Interleukins *
Pharmacology *
Etanercept *
Autoimmune diseases *
Genetic predisposition to disease *
Japan *
Hand dermatoses *
Tendons *
Hyperplasia *
Micrornas *
Autoimmunity *
Ustekinumab *
Prevalence *
Pain *
Drug administration schedule *
Indole alkaloids *
Calcineurin inhibitors *
Islam *
Trpv cation channels *
Th2 cells *
Keratolytic agents *
Aminopeptidases *
Minor histocompatibility antigens *
Nasopharyngitis *
Single-blind method *
Cinnamates *
Tacrolimus *
Odds ratio *
Forkhead transcription factors *
Echocardiography doppler *
Tyk2 kinase *
Medication adherence *
Physician-patient relations *
Immunosuppressive agents *
Nicotinic acids *
Hypoglycemic agents *
Osteitis *
Interleukin-23 *
Psychology *
Raw 264.7 cells *
Focus groups *
Health surveys *
Disease susceptibility *
Antirheumatic agents *
Janus kinase 1 *
Adipokines *
Keratin-16 *
Consensus *
Social class *
Keratin-17 *
Sex distribution *
Aminoquinolines *
Age distribution *
Erythema *
Patient preference *

Results for: Psoriasis

Results from Abstracts

KEGG Pathways

Gene Ontology Biological Processes